Latest Articlesddd

Exelixis Has Good News Today and More is Expected

October 19, 2020 0

Exelixis and Bristol-Myers Squibb sNDA and sBLA Accepted by the FDA Exelixis (EXEL) and Bristol-Myers Squibb …

Tracking COVID-19 Vaccines

October 16, 2020 0

COVID-19 Vaccines from Pfizer/BioNTech and Moderna The three products whose trials were halted are not vaccines …

Cytokinetics Product Omecamtiv Mecarbil for Heart Failure with Reduced Ejection Fraction

October 13, 2020 0

Cytokinetics Omecamtiv Mecarbil for Heat Failure Three biotech firms: Amgen (AMGN), Cytokinetics (

Celldex Therapeutics Doses the First Patient with its CDX-0159 Product for Chronic Spontaneous Urticaria

October 13, 2020 0

Celldex Therapeutics After an expected resurrection, Celldex Therapeutics (CLDX) stock recovered and went as high as …

Filgotinib Has Become Great News for Gilead Sciences and Galapagos NV

October 12, 2020 0

Gilead and Galapagos Granted Marketing Authorization for Filgotinib by the EC Gilead Sciences (GILD) and Galapagos …

Compugen Adds an Immuno-Oncology Pioneer to its Scientific Advisory Board. See Also: The New War Against Aging

October 8, 2020 0

Compugen New Addition, Dr. Nils Lonberg, PhD. Compugen (CGEN) announced the addition of Nils Lonberg, Ph.D., …

An Acquisition & a Collaboration You Must Know About

October 7, 2020 0

Bristol-Myers Squibb Increased activity being observed at Bristol-Myers Squibb (BMY) is aimed at further empowering the …

SARS-CoV-2 Virus vs The President of the United States

October 5, 2020 0

President Trump, the First Lady and COVID-19 Indeed, the complicated, nasty SARS-CoV-2 virus managed to infect …

The FDA Lifted the Clinical Hold on Solid Biosciences’ IGNITE DMD Phase 1/2 Trial Sending the Stock Price Over 131%

October 1, 2020 0

Solid Biosciences Clinical Hold on IGNITE DMD is Lifted by the FDA Solid Biosciences (SLDB) - …

Enlivex Therapeutics Product AllocetraTM Saves Severe/Critical COVID-19 Patients

October 1, 2020 0

Enlivex Therapeutics Positive Results for Severe and Critical COVID-19 Patients Enlivex Therapeutics (ENLV) – a clinical-stage …

Cassava Sciences, Moderna and Sorrento Therapeutics All Have News

September 30, 2020 0

News from Cassava Sciences, Moderna and Sorrento Therapeutics  Cassava Sciences  Cassava Sciences (SAVA) announced that clinical …

Sorrento Therapeutics Releases Preclinical Data from STI-1499 and STI-2020 Demonstrating Potent Neutralizing Antibodies Against SARS-CoV-2

September 29, 2020 0

Sorrento Therapeutics Preclinical Data of Neutralizing Antibodies Against SARS-CoV-2 In preclinical studies, both STI-1499 and STI-2020 …

Johnson & Johnson Launches a Large Scale Phase 3 Trial of Its COVID-19 Vaccine. See Also: Intellia to Prove the Advantages of CRISPR Gene-Editing

September 29, 2020 0

Johnson & Johnson ENSEMBLE Trial for Its COVID-19 Vaccine Candidate Johnson & Johnson (JNJ) announced the …

The Whole World Against the Blind SARS-CoV-2 Virus

September 28, 2020 3

Prohost Letter 442 The Whole World Against the Blind SARS-CoV-2 Virus Investors have no doubt profited …

Revolution Medicines Inc Has Revolutionary News

September 25, 2020 0

Revolution Medicines Inc Revolution Medicines (RVMD) is a clinical-stage precision oncology company focused on developing targeted …

Amgen’s KRAS G12C Inhibitor Product Sotorasib Has Thrilling Results

September 25, 2020 0

Amgen and the KRAS G12C Protein Discovery The RAS gene family has been a subject for four decades …

The EMA Granted PRIME Designation to CRISPR Therapeutics’ and Vertex Pharmaceuticals’ Product CTX001™ for Severe SCD

September 22, 2020 0

Crispr Therapeutics and Vertex Pharmaceuticals CTX001 Granted PRIME Designation by the EMA CRISPR Therapeutics (CRSP) and …

Eli Lilly Neutralizing Antibody LY-CoV555 Promises a Reduction in the Rate of COVID-19 Hospitalizations  

September 16, 2020 0

Eli Lilly and AbCellera Collaboration Result LY-C0V555  A lot of discoveries, followed by thorough experimentation beyond …

Seattle Genetics: Two New Oncology Collaborations with Merck

September 14, 2020 0

Seattle Genetics Two New Strategic Oncology Collaborations with Merck Seattle Genetics (SGEN) and Merck (

Cassava Sciences Promising and Encouraging Results of Its Alzheimer’s Disease Product Sumifilam

September 14, 2020 0

Cassava Sciences Study Results of Sumifilam for Alzheimer's Disease Prohost is happy to inform our subscribers …